Fermenta Biotech Limited (BOM:506414)

India · Delayed Price · Currency is INR

498.35

-4.45 (-0.89%)

At close: Sep 4, 2026

Market Cap	14.29B +48.1%
Revenue (ttm)	5.11B -3.2%
Net Income	596.69M -42.9%
EPS	20.39 -43.0%
Shares Out	28.67M
PE Ratio	24.44
Forward PE	n/a
Dividend	3.75 (0.72%)
Ex-Dividend Date	Aug 5, 2026

Volume	10,287
Open	502.05
Previous Close	502.80
Day's Range	494.00 - 506.20
52-Week Range	256.40 - 579.65
Beta	-0.34
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 11, 2026

About Fermenta Biotech

Fermenta Biotech Limited, together with its subsidiaries, engages in the manufacturing and marketing of chemicals, bulk drugs, enzymes, pharmaceutical formulations, and environmental solution products in India, Europe, the United States, and internationally. It operates through Chemicals/Bulk Drug and Property segments. The company offers vitamin D3, including crystalline oil, resin oil, cold water dispersible, and feed grade powder for injectables, soft gel capsules, premixes, food and beverage fortification applications; and vitamin K1, vitam... [Read more]

Industry Pharmaceutical Preparations

Founded 1951

Employees 630

Stock Exchange Bombay Stock Exchange

Ticker Symbol 506414

Full Company Profile

Financial Performance

In fiscal year 2026, Fermenta Biotech's revenue was 5.25 billion, an increase of 11.92% compared to the previous year's 4.69 billion. Earnings were 717.65 million, a decrease of -6.63%.

Financial Statements